Hospital
ST Mary Medical Center
ST Mary Medical Center was paid $10.76M by Medicaid between Jan 2018 and Dec 2024, across 179 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
33Billing provider infoST MARY MEDICAL CENTER
LANGHORNE, PA 19047
LANGHORNE, PA 19047
33aNPI1780686931assigned 06/01/2005
33bProvider typeRehabilitation Hospital Unit
28Total paid$10.76M
24GClaims105,844
24DCodes billed179
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 190 | $35K | |
| 2019 | 543 | $68K | |
| 2020 | 15,497 | $1.03M | |
| 2021 | 46,051 | $4.04M | |
| 2022 | 8,590 | $1.72M | |
| 2023 | 16,366 | $2.00M | |
| 2024incomplete | 18,607 | $1.86M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 13,984 | 13,560 | $3.77M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 8,545 | 8,209 | $2.38M |
| G0378 | Hospital observation service, per hour | 12% | 718 | 678 | $1.27M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.1% | 3,522 | 3,362 | $978K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.2% | 2,620 | 2,570 | $666K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.3% | 3,182 | 2,985 | $249K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.3% | 1,882 | 1,410 | $137K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 667 | 660 | $91K |
| 59025 | Fetal non-stress test | <1% | 2,118 | 1,122 | $79K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 429 | 421 | $71K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 152 | 151 | $63K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 794 | 719 | $51K |
167 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 498 | $47K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,635 | $47K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 290 | $46K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 489 | $41K |
| 76830 | Ultrasound, transvaginal | <1% | 557 | $39K |
| 76801 | <1% | 546 | $38K | |
| 76813 | <1% | 405 | $35K | |
| 77066 | Tomosynthesis, mammo | <1% | 207 | $35K |
| 76818 | <1% | 289 | $30K | |
| 76642 | <1% | 411 | $29K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 318 | $25K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 396 | $24K |
| 62323 | <1% | 37 | $22K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 56 | $18K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 190 | $18K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 373 | $18K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 198 | $17K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 440 | $16K |
| 76536 | <1% | 179 | $16K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 343 | $15K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 877 | $15K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 204 | $14K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 819 | $14K |
| 77065 | Tomosynthesis, mammo | <1% | 122 | $13K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 217 | $13K |
| 97803 | <1% | 321 | $12K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 29 | $11K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 40 | $11K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 495 | $9K |
| 71250 | <1% | 134 | $9K | |
| 76770 | <1% | 122 | $9K | |
| 73564 | <1% | 249 | $9K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,251 | $8K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 41 | $8K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 120 | $8K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 230 | $8K |
| 93017 | <1% | 97 | $8K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 517 | $7K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 43 | $7K |
| 0002A | <1% | 126 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 576 | $6K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,194 | $6K |
| 80053 | Comprehensive metabolic panel | <1% | 1,923 | $6K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 29 | $6K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 283 | $5K |
| 77062 | <1% | 106 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,918 | $5K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 42 | $5K |
| 90686 | <1% | 663 | $5K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,718 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 111 | $5K |
| 0001A | <1% | 118 | $4K | |
| C1769 | Guide wire | <1% | 41 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,216 | $4K |
| 93971 | <1% | 61 | $4K | |
| 90670 | <1% | 462 | $4K | |
| 97161 | <1% | 28 | $4K | |
| 87486 | <1% | 576 | $4K | |
| 73630 | <1% | 201 | $3K | |
| 72110 | <1% | 73 | $3K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 181 | $3K |
| A9270 | Non-covered item or service | <1% | 2,803 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 233 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 735 | $3K |
| 82248 | <1% | 400 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 31 | $3K |
| 86900 | <1% | 313 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 76 | $3K |
| 77061 | <1% | 57 | $2K | |
| 73030 | <1% | 108 | $2K | |
| 82247 | <1% | 277 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 62 | $2K |
| 90698 | <1% | 304 | $2K | |
| 77080 | <1% | 24 | $2K | |
| 85730 | <1% | 1,181 | $2K | |
| 90680 | <1% | 313 | $2K | |
| 90633 | <1% | 280 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,087 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 158 | $2K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 39 | $2K |
| 90707 | <1% | 233 | $2K | |
| 90716 | <1% | 232 | $2K | |
| 85610 | <1% | 1,322 | $1K | |
| 72100 | <1% | 45 | $1K | |
| 83735 | <1% | 1,160 | $1K | |
| 86850 | <1% | 228 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 577 | $1K |
| 90744 | <1% | 170 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 455 | $1K |
| 76775 | <1% | 12 | $1K | |
| 73130 | <1% | 58 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 149 | $1K |
| 81001 | <1% | 661 | $957.80 | |
| 84702 | <1% | 129 | $929.62 | |
| 90672 | <1% | 128 | $896.00 | |
| 80076 | <1% | 417 | $887.29 | |
| 90651 | <1% | 134 | $868.00 | |
| 73610 | <1% | 42 | $857.29 | |
| 72052 | <1% | 15 | $822.60 | |
| 86901 | <1% | 256 | $790.16 | |
| 90734 | <1% | 100 | $700.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 452 | $686.36 |
| 85027 | <1% | 179 | $646.95 | |
| 90715 | <1% | 94 | $642.98 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 61 | $618.20 |
| 84484 | <1% | 595 | $596.87 | |
| 73110 | <1% | 44 | $590.88 | |
| 90700 | <1% | 84 | $588.00 | |
| 90648 | <1% | 82 | $574.00 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 234 | $533.06 |
| 83690 | <1% | 516 | $484.00 | |
| 87581 | <1% | 558 | $478.80 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 383 | $453.71 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 45 | $436.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 37 | $410.32 |
| 83880 | <1% | 129 | $382.46 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 164 | $365.92 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 41 | $349.00 |
| 81025 | <1% | 373 | $345.35 | |
| 94761 | <1% | 297 | $309.39 | |
| 99188 | <1% | 17 | $306.00 | |
| J2704 | Injection, propofol, 10 mg | <1% | 920 | $294.80 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 697 | $277.64 |
| 90696 | <1% | 39 | $273.00 | |
| 87040 | <1% | 164 | $257.60 | |
| 83605 | <1% | 222 | $255.60 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 29 | $242.94 |
| 81003 | <1% | 346 | $218.46 | |
| 80061 | Lipid panel | <1% | 32 | $212.24 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 34 | $200.39 |
| 85379 | <1% | 143 | $190.80 | |
| 96376 | <1% | 28 | $136.15 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,700 | $116.40 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 140 | $106.89 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 93 | $88.79 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,023 | $71.23 |
| 90685 | <1% | 409 | $63.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,995 | $57.25 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 683 | $50.73 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 790 | $44.88 |
| 86140 | <1% | 75 | $27.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 501 | $22.49 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 319 | $22.30 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,742 | $21.70 |
| 87186 | <1% | 16 | $19.60 | |
| 87077 | <1% | 17 | $17.40 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 76 | $15.46 |
| 87070 | <1% | 83 | $14.80 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 496 | $7.01 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 281 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 48 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 151 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 165 | $0.00 |
| 99173 | 0% | 114 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 137 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 127 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 24 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 14 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 14 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 13 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 15 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 160 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 170 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 66 | $0.00 |
| 92551 | 0% | 53 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 35 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPALLUCCI, MARYANNE (THMA REGIONAL CFO)
| Provider | Location | Paid |
|---|---|---|
| ST Mary Medical Center | Bensalem, PA | $156K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.